BRAF V600E Mutation Analysis in Papillary Thyroid Carcinomas by Peptide Nucleic Acid Clamp Real-time PCR

BRAFV600E mutation in the pathogenesis of a large series of papillary thyroid carcinoma in Czech Republic

(2014) V. Sykorova et al.   JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION

Is the BRAFV600E mutation useful as a predictor of preoperative risk in papillary thyroid cancer?

(2011) Jung Kwang Nam et al.   AMERICAN JOURNAL OF SURGERY

Rapid and Sensitive Detection ofKRASMutation by Peptide Nucleic Acid-based Real-time PCR Clamping: A Comparison with Direct Sequencing between Fresh Tissue and Formalin-fixed and Paraffin Embedded Tissue of Colorectal Cancer

(2011) Dongjun Jeong et al.   Korean Journal of Pathology

Association of High Iodine Intake with the T1799ABRAFMutation in Papillary Thyroid Cancer

(2009) Haixia Guan et al.   JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM

LightCycler Technology in Molecular Diagnostics

(2009) Elaine Lyon et al.   JOURNAL OF MOLECULAR DIAGNOSTICS

BRAFV600E Mutation and X-Linked Inhibitor of Apoptosis Expression in Papillary Thyroid Carcinoma

(2009) Li-Qun Gu et al.   THYROID

BRAF Silencing by Short Hairpin RNA or Chemical Blockade by PLX4032 Leads to Different Responses in Melanoma and Thyroid Carcinoma Cells

(2008) E. Sala et al.   MOLECULAR CANCER RESEARCH

Clinical and Pathological Features and the BRAFV600E Mutation in Patients with Papillary Thyroid Carcinoma with and without Concurrent Hashimoto Thyroiditis

(2008) Suk Kyeong Kim et al.   THYROID